You are here

Exit strategies in IBD: When should we stop drugs, take a drug holiday, or continue unchanged

E. Louis

5-2 Exit Strategy In IBD

On drug exit strategies, Edouard Louis noted that immunosuppressant and anti-TNF withdrawal is associated with an increased risk of disease relapse in both UC and CD. However, subgroups of patients in CD who are in deep remission, have normalised biomarkers and mucosal healing, have shown lower risk of relapse. Treatment withdrawal and cycles should take into account individual by cost-effectiveness, the benefit-risk profile considering patient history, risks of side effects, mucosal healing and signs of persisting inflammation.



Subscribe to our E-Alert to stay informed of all new content as it's published on this platform.

IBD 13.03.2015

Visit the journal website!

Search form